Serotonin reuptake inhibitors and bleeding risks in major orthopedic procedures

Psychosomatics

Volumn 53, Issue 6, 2012, Pages 559-565

  Tavakoli, Hamid R ^a   DeMaio, Marlene ^a   Wingert, Nathaniel C ^b   Rieg, Thomas S ^a   Cohn, Julie A ^a   Balmer, Russell P ^c   Dillard, Marie A ^a  

^a NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

^b GEISINGER MEDICAL CENTER   (United States)

^c Camp Lejeune Naval Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; HEMOGLOBIN; MIRTAZAPINE; PAROXETINE; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADULT; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMATOCRIT; HUMAN; INTERNATIONAL NORMALIZED RATIO; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PROTHROMBIN TIME; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE; THROMBOCYTE AGGREGATION; TOTAL HIP PROSTHESIS;

ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; CASE-CONTROL STUDIES; FEMALE; HEMATOLOGIC TESTS; HUMANS; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; PLATELET AGGREGATION; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 84875803069     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2012.05.001     Document Type: Article

References (37)

1. Looper K.J. Potential medical and surgical complications of serotonergic antidepressant medications. Psychosomatics 2007, 48(1):1-9.
2. Pirraglia P.A., Stafford R.S., Singer D.E. Trends in prescribing of selective serotonin reuptake Inhibitors and other newer antidepressant agents in adult primary care. Prim Care Companion J Clin Psychiatry 2003, 5(4):153-157.
3. Ray W.A., Meredith S., Thapa P.B., Hall K., Murray K.T. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 2004, 75(3):234-241.
4. Bierbaum B.E., Callaghan J.J., Galante J.O., Rubash H.E., Tooms R.E., Welch R.B. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999, 81(1):2-10.
5. Lemos M.J., Healy W.L. Blood transfusion in orthopaedic operations. J Bone Joint Surg Am 1996, 78(8):1260-1270.
6. Mylod A.G., France M.P., Muser D.E., Parsons J.R. Perioperative blood loss associated with total knee arthroplasty. A comparison of procedures performed with and without cementing. J Bone Joint Surg Am 1990, 72(7):1010-1012.
7. Toy P.T., Kaplan E.B., McVay P.A., Lee S.J., Strauss R.G., Stehling L.C. Blood loss and replacement in total hip arthroplasty: a multicenter study. The Preoperative Autologous Blood Donation Study Group. Transfusion 1992, 32(1):63-67.
8. van Haelst I.M., Egberts T.C., Doodeman H.J., Traast H.S., Burger B.J., Kalkman C.J., et al. Use of serotonergic antidepressants and bleeding risk in orthopedic patients. Anesthesiology 2010, 112(3):631-636.
9. Movig K.L., Janssen M.W., de Waal Malefijt J., Kabel P.J., Leufkens H.G., Egberts A.C. Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med 2003, 163(19):2354-2358.
10. Barbui C., Andretta M., De Vitis G., Rossi E., D'Arienzo F., Mezzalira L., et al. Antidepressant drug prescription and risk of abnormal bleeding: a case-control study. J Clin Psychopharmacol 2009, 29(1):33-38.
11. Dall M., Schaffalitzky de Muckadell O.B., Lassen A.T., Hansen J.M., Hallas J. An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding. Clin Gastroenterol Hepatol 2009, 7(12):1314-1321.
12. Dalton S.O., Johansen C., Mellemkjaer L., Norgard B., Sorensen H.T., Olsen J.H. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 2003, 163(1):59-64.
13. de Abajo F.J., Garcia-Rodriguez L.A. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry 2008, 65(7):795-803.
14. de Abajo F.J., Rodriguez L.A., Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 1999, 319(7217):1106-1109.
15. Helin-Salmivaara A., Huttunen T., Gronroos J.M., Klaukka T., Huupponen R. Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population. Eur J Clin Pharmacol 2007, 63(4):403-408.
16. Loke Y.K., Trivedi A.N., Singh S. Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and nonsteroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2008, 27(1):31-40.
17. Meijer W.E., Heerdink E.R., Nolen W.A., Herings R.M., Leufkens H.G., Egberts A.C. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 2004, 164(21):2367-2370.
18. Opatrny L., Delaney J.A., Suissa S. Gastrointestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. Br J Clin Pharmacol 2008, 66(1):76-81.
19. Targownik L.E., Bolton J.M., Metge C.J., Leung S., Sareen J. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. Am J Gastroenterol 2009, 104(6):1475-1482.
20. Tata L.J., Fortun P.J., Hubbard R.B., Smeeth L., Hawkey C.J., Smith C.J., et al. Does concurrent prescription of selective serotonin reuptake inhibitors and nonsteroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?. Aliment Pharmacol Ther 2005, 22(3):175-181.
21. van Walraven C., Mamdani M.M., Wells P.S., Williams J.I. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 2001, 323(7314):655-658.
22. Vidal X., Ibanez L., Vendrell L., Conforti A., Laporte J.R. Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants: a case-control study. Drug Saf 2008, 31(2):159-168.
23. Wessinger S., Kaplan M., Choi L., Williams M., Lau C., Sharp L., et al. Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther 2006, 23(7):937-944.
24. Ziegelstein R.C., Meuchel J., Kim T.J., Latif M., Alvarez W., Dasgupta N., et al. Selective serotonin reuptake inhibitor use by patients with acute coronary syndromes. Am J Med 2007, 120(6):525-530.
25. Andreasen J.J., Riis A., Hjortdal V.E., Jorgensen J., Sorensen H.T., Johnsen S.P. Effect of selective serotonin reuptake inhibitors on requirement for allogeneic red blood cell transfusion following coronary artery bypass surgery. Am J Cardiovasc Drugs 2006, 6(4):243-250.
26. Kim D.H., Daskalakis C., Whellan D.J., Whitman I.R., Hohmann S., Medvedev S., et al. Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting. Am J Cardiol May 15 2009, 103(10):1391-1395.
27. Van Cann E.M., Koole R. Abnormal bleeding after an oral surgical procedure leading to airway compromise in a patient taking a selective serotonin reuptake inhibitor and a nonsteroidal antiinflammatory drug. Anesthesiology 2008, 109(3):568-569.
28. Salkeld E., Ferris L.E., Juurlink D.N. The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants. J Clin Psychopharmacol 2008, 28(2):230-234.
29. Andrade C., Sandarsh S., Chethan K.B., Nagesh K.S. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry 2010, 71(12):1565-1575.
30. Halperin D., Reber G. Influence of antidepressants on hemostasis. Dialogues Clin Neurosci 2007, 9(1):47-59.
31. Hergovich N., Aigner M., Eichler H.G., Entlicher J., Drucker C., Jilma B. Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther 2000, 68(4):435-442.
32. Lesch K.P., Wolozin B.L., Murphy D.L., Reiderer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem 1993, 60(6):2319-2322.
33. Li N., Wallen N.H., Ladjevardi M., Hjemdahl P. Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis 1997, 8(8):517-523.
34. Sauer W.H., Berlin J.A., Kimmel S.E. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation 2003, 108(1):32-36.
35. Serebruany V.L. Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something?. Am J Med 2006, 119(2):113-116.
36. Serebruany V.L., O'Connor C.M., Gurbel P.A. Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease. Am J Cardiol 2001, 87(12):1398-1400.
37. Skop B.P., Brown T.M. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics 1996, 37(1):12-16.